In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert ...
Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.
A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.
From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...
A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, ...
SOXRC Regimen Improves Responses Versus Chemo Alone in Advanced Gastric Cancers ...
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...
Embrace Gratitude: I must reflect on what I’m thankful for each year. This practice reshaped my perspective on life. Create a ...
The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...
Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain ...
Enhertu maintained HRQOL and neurological function in HER2-positive metastatic breast cancer patients, regardless of brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback